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SUMMARY
Baypamun® is an immunity modulator recommended as prophylactic and therapeutic use. In the present study, this product was used in
the hamsters experimentally infected with Leptospira interrogans serogroup canicola. The animals were divided in 5 groups, with 20
animals each. This product was used as a therapeutic, prophylactic and as adjuvant. As a therapeutic use all the animals died. Despite of
eight (40.0%) survivors, the prophylactic use wasn’t also totally favorable due to leptospire recovering from kidneys of those animals.
Based on the analysis of antibodies levels among animals that received vaccine and vaccine with Baypamun ® as adjuvante, this product
didn’t conferred superior humoral answer. However, other studies should be accomplished utilizing this product in a longer period as
well as verify the cellular answer by Baypamun® use as adjuvant in the infectious disease.
UNITERMS: Immunomodulators; Leptospira; Immunity.
INTRODUCTION
aypamun® is an immune modulator, produced with
Parapoxvirus ovis D1701 strain, that stimulates the
unspecific immune response and is recommended for
prevention and treatment of infectious diseases. This product,
studied in several animal species, improved the concentration of
antibodies in the milk of primiparous sows, and increased the
survival of piggies14. In the same specie, the treatment of
reproductive diseases and respiratory syndromes with Baypa-
mun® reduced the mortality and increased the body weight
rate7.
In spite of the prophylactic and therapeutic action of
Baypamun, it presented poor or completely negative results in
the occurrence of respiratory diseases complex in felines10 but
the paraimunization was effective in leucemics cats9. Ovines
with diarrhoea recovered in a few days after treatment4. Rabbits
with traveling diseases caused by Pasteurella multocida, Bordetella
bronchiseptica or Mycoplasma sp., and induced by different
stress factors, had their occurrence reduced with Baypamun
treatment1.
There are no reports about the influence of Baypamun®
over the course of Leptospirosis, however, Alves et al.2 found that
BCG enhanced the resistance of hamsters experimentally infected
with serovar pomona, Ris and Hamel12, observed that Freund’s
complete adjuvant was better than aluminum hydroxide in
commercial vaccines produced with sorovar pomona. The present
work aimed to verify the influence of Baypamun as a paraimmu-
nizer in hamsters experimentally infected with Leptospira
interrogans serogroup Canicola.
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MATERIAL AND METHOD
One hundred female hamsters (Mesocricetus auratus)
were used with weights varying 60 to 80 gm. The animals were
conditioned in plastic boxes, 20 per group, observed twice a day,
for 21 days, with daily annotations of the clinical alterations.
Before the inoculations, animals’ serums were examined
to verify the presence of antileptospira agglutinins. The blood was
obtained through heart puncture and the serum was stored in flasks
type “vaccines” maintained in freezer (-20ºC). Microscopic
agglutination test (MAT) was used to serological analysis, at the
screening dilution of 1:1005.
The experimental infection was performed with a virulent
strain of Canicola serogroup, cultivated in Flecther medium. For
each animal the infectious inocula was 0,5 ml, with 106
microorganisms/ml by intra-peritoneal route13. The animals that
reached the agonic state of the disease as well as the survivors
were killed and examined searching for macroscopic alterations.
Before the sacrifice, it was collected blood samples for anti-
leptospire agglutinins determination study.
The animals were divided in five groups, with 20 animals
each. The Group 1 was the infectious innoculum control, and
received only leptospires culture. The Group 2 was treated with
0,5 ml doses of Baypamun® applied on four and two days before
experimental infection. The Group 3 received two vaccine doses
using Baypamun® as adjuvant, 0.5 ml of each one, into interval of
15 days, challenged 15 days after the last inoculation. Likely to
Group 3, the Group 4 only didn’t receive Baypamun®. In the Group
5, this product was applied four and six days after experimental
infection, with doses of 0,5 ml each.
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The vaccine was prepared according to Avila et al.3
starting from leptospire liquid culture. The inactivation was done
by 0.1% formalin solution, and the culture was centrifuged at
10,000 rpm during two hours and ressuspended in physiologic
saline solution containing 0.18% red phenol, and adjusted for 4.0
x 108 leptospires/ml.
After performing the necropsies exams it were collected
liver and kidneys samples, which were macerated separately. Saline
solution with neomycin and nitrofurantoin in the concentration of
25 µgl/ml of each drug11, was added in the proportion of 1/10.
Serial decimal dilutions until 10-3 was cultivated using Fletcher
medium. Pasteur pipette technique was also utilized for organs
cultivation8. The flasks were incubated at 30ºC, during 60 days,
for the observation of Dinger’s zone.
The macerated tissue was examined under dark field
microscopic of searching for leptospires. Serological results was
statistical analysed by Mann-Whitney Test, with α = 0.05
significant level.
RESULTS AND DISCUSSION
All the serum samples previously obtained were MAT
negative. Antibodies titres ranged from negatives, in animals died
until six days after infection, to 12,800 in the next days, in the
Groups 1, 2 e 5.
In the Groups 3 and 4, respectively, titres ranged from
200 to 1,600 and 200 to 3,200. There was no statistical differences
between two immunization schedules employed, with p > 0.05.
In the Group 1, seven (35.0%) animals died in the 6th
day, eight (40.0%) in the 7th day, three (15.0%) in the 8th day, and
two (10,0%) in the 9th day after infection. In the Group 2, eight
(40.0%) animals survived, two (10.0%) died in the 6th day, four
(20.0%) in the 7th day, two (10.0%) in the 8th day, two (10.0%) in
the 9th day and two (10.0%) in the 12th day after the experimental
inoculation. In the Group 5, 10 (50.0%) animals died in the 6th
day, two (10.0%) in the 7th day, six (30.0%) in the 8th day, and
two (10.0%) in the 9th day after infection. All the animals survived
in the Groups 3 and 4.
The clinical signals observed were apathy, anorexia,
dehydration, bristly hair, incoordination and moderate jaundice.
The symptoms also were present in the eight (40.0%) survivors
animals from Group 2, but they recovered and survived. Alterations
were not observed in the Groups 3 and 4, which presented no
clinical signs.
The reisolation was obtained from all the animals from
Groups 1, 2 and 5, including the eight (40.0%) survivors from
Group 2. Positive culture was not obtained in the Groups 3 and 4.
Liver and kidneys were congested and hemorrhagic at
necropsy. Petechiaes and suffusions were observed in the lungs
surface and moderate jaundice in epiplon and abdominal
musculature.
Pasteur pipette technique was more effective for
recovering leptospires, once the cultivation by serial dilution was
positive in only one animal from Group 1. The first technique
presents higher contamination risk, but with the necessary care
can be avoided.
Baypamun® used as therapeutic form didn’t give
protection against leptospire infection in Group 5. In spite of eight
(40.0%) animals that survived from Group 2, the prophylactic
wasn’t also totally favorable, due to recovering leptospire from
kidneys of these animals, which means they became kidney carriers
of leptospires.
Based on analysis of antibodies levels among animals from
Groups 3 and 4, Baypamun® didn’t increased humoral response.
However, other studies should be accomplished utilizing this
product in a longer period as well as verifying the cellular response.
RESUMO
Baypamun® é um imunomodulador recomendado na profilaxia e terapêutica de enfermidades. No presente estudo, este produto foi usado
em hamsters experimentalmente infectados com Leptospira interrogans, sorogrupo canicola. Estes animais foram divididos em 5 grupos
com 20 animais cada. O produto foi usado como terapêutico, profilático e como adjuvante. Quando usado de forma terapêutica, todos os
animais vieram a óbito. Quando usado na profilaxia, 8 animais (40%) sobreviveram e foi possível recuperar o agente a partir dos rins
desses animais. Baseado na análise do título de anticorpos nos animais que receberam ou não o Baypamun como adjuvante vacinal, o
produto não elevou a resposta humoral. Os resultados sugerem, entretanto, outros estudos que utilizem o produto por períodos mais
prolongados, além de se verificar a resposta celular para se avaliar o seu efeito como adjuvante nas infecções.
UNITERMOS: Imunomoduladores; Leptospira; Imunidade.
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